131 related articles for article (PubMed ID: 7538180)
1. [Clinicopathological studies of anti-HCV P1P4 core antibody].
Shibuya A; Asano A; Tsuchihashi T; Sakurai K; Takeuchi A; Shibata H
Rinsho Byori; 1995 Mar; 43(3):285-9. PubMed ID: 7538180
[TBL] [Abstract][Full Text] [Related]
2. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
3. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
4. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
5. [Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy].
Kaji K; Unoura M; Kobayashi K; Nakanuma Y
Nihon Rinsho; 1994 Jul; 52(7):1865-8. PubMed ID: 7521432
[TBL] [Abstract][Full Text] [Related]
6. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
[TBL] [Abstract][Full Text] [Related]
7. [Summary and evaluation of genome and antibody diagnosis in hepatitis C virus infection].
Nishizono A
Rinsho Byori; 1994 Dec; 42(12):1240-7. PubMed ID: 7532727
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
9. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of determination of anti-HCV antibodies].
Takase K; Tameda Y; Kosaka Y
Rinsho Byori; 1994 Oct; 42(10):1003-9. PubMed ID: 7527869
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia.
Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R
Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
13. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
Nagayama R; Shoji S; Miyake K
Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
[TBL] [Abstract][Full Text] [Related]
14. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
15. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
17. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
[TBL] [Abstract][Full Text] [Related]
18. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
[TBL] [Abstract][Full Text] [Related]
19. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
